Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Baxter Healthcare Corporation
FDA Inspection
•Baxter Healthcare Corporation•February 9, 2024

Baxter Healthcare Corporation – FDA Inspection, Feb 9, 2024

Record Details

This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on February 9, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Baxter Healthcare Corporation
Inspection Date
February 9, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Demario L. Walls (Investigator)
  • Libia M. Lugo (Issuing Officer)
  • Susan T. Hadman (FDA Associated Person)
  • Veronica Fuentes (FDA Associated Person)
View Company Profile

ID · af306a83-c8f6-4639-8e6c-5d8b74cc7791

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1230544
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

7
  1. 21 CFR 211.110(a)Control procedures fail to include the following
  2. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.198(a)Complaint Handling Procedure
  5. 21 CFR 211.192Investigations of discrepancies, failures
  6. 21 CFR 211.22(d)Procedures not in writing, fully followed
  7. 21 CFR 211.100(a)Absence of Written Procedures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Baxter Healthcare Corporation

10
DateClassificationOfficeProject area
October 31, 2023OAICenter for Biologics Evaluation and ResearchBlood and Blood Products
May 12, 2022OAICenter for Biologics Evaluation and ResearchBlood and Blood Products
July 1, 2021NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 17, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 26, 2016OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for Baxter Healthcare Corporation
  • FDA Inspection 1221559 - 2023-10-31
  • FDA Inspection 1169330 - 2022-05-12
  • FDA Inspection 1151566 - 2021-07-01
  • FDA Inspection 1031655 - 2017-11-17
  • FDA Inspection 969544 - 2016-02-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Baxter Healthcare Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.